Related Experiment Video
Updated: Feb 4, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
NKX2-1-AS1 negatively regulates CD274/PD-L1, cell-cell interaction genes, and limits human lung carcinoma cell
Hasmeena Kathuria1, Guetchyn Millien1, Liam McNally1
1The Pulmonary Center, Boston University School of Medicine, 72 E. Concord St, Boston, MA, 02118, USA.
Abstract:
The function of most long noncoding RNAs (lncRNAs) is unknown. However, recent studies reveal important roles of lncRNAs in regulating cancer-related pathways. Human antisense lncRNA-NKX2-1-AS1 partially overlaps the NKX2-1/TTF1 gene within chromosomal region 14q13.3. Amplification of this region and/or differential expression of genes therein are associated with cancer progression. Herein we show higher levels of NKX2-AS1 and NKX2-1 in lung adenocarcinomas relative to non-tumor controls but no correlation between NKX2-1-AS1 and NKX2-1 levels across specimens, or with amplification of the 14q13.3 region, suggesting that NKX2-1-AS1 and NKX2-1 are independently regulated. Loss-and-gain of function experiments showed that NKX2-1-AS1 does not regulate NKX2-1 expression, or nearby genes, but controls genes in trans. Genes up-regulated by NKX2-1-AS1-knockdown belong to cell adhesion and PD-L1/PD-1 checkpoint pathways. NKX2-1-AS1 negatively regulates endogenous CD274/PD-L1, a known target of NKX2-1, and the transcriptional activity of -1kb-CD274 promoter-reporter construct. Furthermore, NKX2-1-AS1 interferes with NKX2-1 protein binding to the CD274-promoter, likely by NKX2-1 protein-NKX2-1-AS1 interactions. Finally, NKX2-1-AS1 negatively regulates cell migration and wound healing, but not proliferation or apoptosis. These findings support potential roles of NKX2-1-AS1 in limiting motility and immune system evasion of lung carcinoma cells, highlighting a novel mechanism that may influence tumorigenic capabilities of lung epithelial cells.
Insights
Long noncoding RNA NKX2-1-AS1 is elevated in lung cancer and independently regulated. It limits cell migration and immune evasion by downregulating PD-L1, suggesting a role in controlling lung carcinoma progression.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
- The human antisense lncRNA-NKX2-1-AS1 is located near the NKX2-1 gene on chromosome 14q13.3, a region implicated in cancer progression.
Purpose of the Study:
- To investigate the role of lncRNA-NKX2-1-AS1 in lung adenocarcinoma.
- To determine the regulatory relationship between NKX2-1-AS1, NKX2-1, and cancer-related pathways.
Main Methods:
- Quantitative PCR to measure NKX2-1-AS1 and NKX2-1 levels.
- Loss-and-gain of function experiments (knockdown and overexpression).
- Reporter assays to assess promoter activity and protein-DNA interactions.
Main Results:
- NKX2-1-AS1 and NKX2-1 are upregulated in lung adenocarcinomas but independently regulated.
- NKX2-1-AS1 knockdown upregulates genes in cell adhesion and PD-L1/PD-1 pathways.
- NKX2-1-AS1 negatively regulates PD-L1 expression and cell migration, potentially via interaction with NKX2-1 protein.
Conclusions:
- NKX2-1-AS1 acts independently of NKX2-1 to regulate genes in trans, including PD-L1.
- NKX2-1-AS1 may limit lung carcinoma cell motility and immune evasion, presenting a novel therapeutic target.
Related Concept Videos
Negative Regulator Molecules
Cell Specific Gene Expression
Cell Migration
Cell Migration
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Cancer Cell Migration through Invadopodia

